FDA Shames Anti-Generic Tactics, Putting Onus On Congress

FDA Shames Anti-Generic Tactics, Putting Onus On Congress

The U.S. Food and Drug Administration on Thursday named and shamed drugmakers suspected of impeding lower-cost generics by withholding product samples, a splashy move that could jolt Congress into taking action. ...read more

  • Tags: